Vascular endothelial growth factor-D transgenic mice show enhanced blood capillary density, improved postischemic muscle regeneration, and increased susceptibility to tumor formation

Blood

Volumn 113, Issue 18, 2009, Pages 4468-4475

  Kärkkäinen, Anna Mari ^a   Kotimaa, Antti ^a   Huusko, Jenni ^a   Kholova, Ivana ^a   Heinonen, Suvi Elina ^a   Stefanska, Anna ^a   Dijkstra, Marike Hinke ^a   Purhonen, Hanna ^a   Hämäläinen, Eveliina ^a   Mäkinen, Petri Ilmari ^a   Turunen, Mikko Petri ^a   Ylä Herttuala, Seppo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; MESSENGER RNA; VASCULOTROPIN D; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; CANCER MORPHOLOGY; CANCER MORTALITY; CANCER SUSCEPTIBILITY; CAPILLARY DENSITY; CARCINOGENESIS; CLINICAL CHEMISTRY; CONTROLLED STUDY; FEMALE; GERM LINE; HEART; HEART MUSCLE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LIMB ISCHEMIA; LUNG TUMOR; METASTASIS; MORTALITY; MOUSE; MUSCLE REGENERATION; NONHUMAN; PANCREAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; SKIN; SKIN TUMOR; SPLEEN; TRANSGENE; TRANSGENIC MOUSE; TRANSGENICS; VASCULARIZATION; ANIMAL; CAPILLARY; CYTOLOGY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL NEOPLASM; GENETICS; HINDLIMB; HUMAN; LENTIVIRINAE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE;

ANIMALS; CAPILLARIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HINDLIMB; HUMANS; IMMUNOENZYME TECHNIQUES; ISCHEMIA; LENTIVIRUS; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; NEOPLASMS, EXPERIMENTAL; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 66149103218     PISSN: 00064971     EISSN: 15280020     Source Type: None    
DOI: 10.1182/blood-2008-07-171108     Document Type: Article

References (23)

1. Millauer B, Wizigmann-Voos S, Schnürch H, et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 1993;72: 835-846. (Pubitemid 23110226)
2. Karkkainen MJ, Haiko P, Sainio K, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immun. 2003;5:74-80. (Pubitemid 38081471)
3. Tammela T, Saaristo A, Holopainen T, et al. Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat Med. 2007;13:1458-1466. (Pubitemid 350224251)
4. Yamazaki Y, Morita T. Molecular and functional diversity of vascular endothelial growth factors. Mol Div. 2006;10:515-527. (Pubitemid 44885229)
5. Kärpänen T, Heckman CA, Keskitalo S, et al. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J. 2006;20: 1462-1472. (Pubitemid 44943854)
6. McColl BK, Paavonen K, Karnezis T, et al. Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2. FASEB J. 2007;21:1088-1098. (Pubitemid 46495698)
7. Stacker SA, Stenvers K, Caesar C, et al. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem. 1999; 274:32127-32136. (Pubitemid 129503808)
8. Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol. 1999;237:97-132. (Pubitemid 28554861)
9. Veikkola T, Jussila L, Makinen T, et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J. 2001;20:1223-1231. (Pubitemid 32233963)
10. Baldwin ME, Catimel B, Nice EC, et al. The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man. J Biol Chem. 2001;276:19166-19171. (Pubitemid 37411247)
11. Huusko J, Mäkinen PI, Alhonen L, Ylä-Herttuala S. Generation of transgenic and knockdown mice with lentiviral vectors and RNAi techniques. In: Latterich M eds. RNAi. BIOS advanced methods. Boca Raton, FL: Taylor & Francis Group; 2008: 91-108.
12. Kankkonen HM, Turunen MP, Hiltunen MO, et al. Feline immunodeficiency virus and retrovirus-mediated adventitial ex vivo gene transfer to rabbit carotid artery using autologous vascular smooth muscle cells. J Mol Cell Cardiol. 2004;36: 333-341.
13. Tiscornia G, Tergaonkar V, Galimi F, Verma IM. CRE recombinase-inducible RNA interference mediated by lentiviral vectors. Proc Natl Acad Sci U S A. 2004;101:7347-15731 (Pubitemid 38638035)
14. Kholová I, Koota S, Kaskenpää N, et al. Adenovirus- mediated gene transfer of human vascular endothelial growth factor-d induces transient angiogenic effects in mouse hind limb muscle. Hum Gene Ther. 2007;18:232-244. (Pubitemid 46626462)
15. Hofmann A, Kessler B, Ewerling S, et al. Epigenetic regulation of lentiviral transgene vectors in a large animal model. Mol Ther. 2006;13:59-66. (Pubitemid 41763483)
16. Wirzenius M, Tammela T, Uutela M, et al. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. Exp Med. 2007;204:1431-1440. (Pubitemid 46919880)
17. Rissanen TT, Markkanen JE, Gruchala M, et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res. 2003;92:1098-1106. (Pubitemid 36665855)
18. Rutanen J, Rissanen TT, Markkanen JE, et al. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation. 2004; 109:1029-1035. (Pubitemid 38282857)
19. Baldwin ME, Halford MM, Roufail S, et al. Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol Cell Biol. 2005;25:2441-2449. (Pubitemid 40354637)
20. Currie MJ, Hanrahan V, Gunningham SP, et al. Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas. J Clin Pathol. 2004; 57:829-834. (Pubitemid 39061431)
21. Van den Eynden GG, Van Laere SJ, Van der Auwera I, et al. Differential expression of hypoxia and (lymph)angiogenesis-related genes at different metastatic sites in breast cancer. Clin Exp Metastasis. 2007;24:13-23.
22. Akahane M, Akahane T, Shah A, Okajima E, Thorgeirsson UP. A potential role for vascular endothelial growth factor-D as an autocrine growth factor for human breast carcinoma cells. Anticancer Res. 2005;25:701-707. (Pubitemid 40546834)
23. Weigand M, Hantel P, Kreienberg R, Waltenberger J. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro. Angiogenesis. 2005;8:197-204..